Decoding Novavax's Options Activity: What's the Big Picture?
Decoding Novavax's Options Activity: What's the Big Picture?
Whales with a lot of money to spend have taken a noticeably bullish stance on Novavax.
有大量资金可用的鲸鱼已经明显看好诺瓦瓦克斯医药。
Looking at options history for Novavax (NASDAQ:NVAX) we detected 10 trades.
我们检测到了10笔诺瓦瓦克斯医药期权交易历史记录。
If we consider the specifics of each trade, it is accurate to state that 80% of the investors opened trades with bullish expectations and 20% with bearish.
如果我们考虑每个交易的具体情况，可以准确地说80%的投资者以看好的预期开仓，20%以看淡的预期开仓。
From the overall spotted trades, 3 are puts, for a total amount of $238,432 and 7, calls, for a total amount of $255,012.
从整个检测到的交易来看，有3份看跌期权，总金额为238,432美元，有7份看涨期权，总金额为255,012美元。
Predicted Price Range
预测价格区间
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $7.5 to $17.5 for Novavax over the last 3 months.
考虑到这些合同的成交量和持仓量，过去3个月来，鲸鱼们已经将目标价位定在了7.5美元至17.5美元之间。
Insights into Volume & Open Interest
成交量和持仓量分析
In today's trading context, the average open interest for options of Novavax stands at 1732.0, with a total volume reaching 953.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Novavax, situated within the strike price corridor from $7.5 to $17.5, throughout the last 30 days.
在今天的交易环境中，诺瓦瓦克斯医药期权的平均持仓量为1732.0，总成交量为953.00。下图描述了过去30天内位于7.5美元至17.5美元行权价格走廊内的高价值交易的看涨和看跌期权成交量和持仓量的进展情况。
Novavax Option Volume And Open Interest Over Last 30 Days
诺瓦瓦克斯医药期权成交量和持仓量过去30天的情况
Largest Options Trades Observed:
观察到的最大期权交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | PUT | SWEEP | BULLISH | 01/17/25 | $0.79 | $0.66 | $0.66 | $7.50 | $108.3K | 3.5K | 4 |
| NVAX | PUT | SWEEP | BEARISH | 07/12/24 | $2.27 | $1.98 | $2.02 | $15.00 | $72.9K | 27 | 0 |
| NVAX | PUT | SWEEP | BULLISH | 01/17/25 | $6.2 | $6.15 | $6.15 | $17.50 | $57.2K | 3.0K | 1 |
| NVAX | CALL | TRADE | BULLISH | 01/16/26 | $7.9 | $7.3 | $7.86 | $7.50 | $39.3K | 1.7K | 150 |
| NVAX | CALL | TRADE | BULLISH | 01/16/26 | $7.9 | $7.3 | $7.75 | $7.50 | $38.7K | 1.7K | 100 |
| 标的 | 看跌/看涨 | 交易类型 | 情绪 | 到期日 | 卖盘 | 买盘 | 价格 | 执行价格 | 总交易价格 | 未平仓合约数量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | 看跌 | SWEEP | 看好 | 01/17/25 | $0.79 | $0.66 | $0.66 | $7.50 | $108.3K | 3.5K | 4 |
| NVAX | 看跌 | SWEEP | 看淡 | 07/12/24 | 2.27美元 | $1.98 | $2.02 | 15.00美元 | $72.9K | 27 | 0 |
| NVAX | 看跌 | SWEEP | 看好 | 01/17/25 | $6.2 | $ 6.15 | $ 6.15 | $17.50 | $57.2K | 3.0K | 1 |
| NVAX | 看涨 | 交易 | 看好 | 01/16/26 | $7.9 | $7.3 | $7.86 | $7.50 | $39.3K | 1.7K | 150 |
| NVAX | 看涨 | 交易 | 看好 | 01/16/26 | $7.9 | $7.3 | $7.75 | $7.50 | $38.7K | 1.7K | 100 |
About Novavax
关于诺瓦瓦克斯
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.
诺瓦瓦克斯公司是一家开发疫苗的生物技术公司。该公司在开发的临床阶段致力于推出预防广泛疾病的新产品。诺瓦瓦克斯与其全资拥有的瑞典子公司合作，生产能够应对已知和新出现的疾病威胁的疫苗候选品。该公司认为其疫苗技术具有广泛应用于多种人类传染性疾病的潜力。该公司将其业务管理为一个经营部门，即疫苗的研发和商业化。该公司从欧洲获取最大收入。
In light of the recent options history for Novavax, it's now appropriate to focus on the company itself. We aim to explore its current performance.
鉴于诺瓦瓦克斯的近期期权交易历史，现在适合关注该公司本身。我们旨在探讨其当前表现。
Novavax's Current Market Status
诺瓦瓦克斯医药的当前市场状态
- Trading volume stands at 5,226,531, with NVAX's price down by -7.32%, positioned at $12.97.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 41 days.
- 交易量为5,226,531股，NVAX的价格下跌了-7.32%，位于12.97美元位置。
- RSI指标显示该股票目前处于超买和超卖之间的中立状态。
- 盈利公告预计还有41天。
Professional Analyst Ratings for Novavax
诺瓦瓦克斯医药的专业分析师评级
A total of 1 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $18.0.
在过去30天中，共有1位专业分析师对这只股票发表了看法，设定了平均目标价为18.0美元。
- Consistent in their evaluation, an analyst from B of A Securities keeps a Neutral rating on Novavax with a target price of $18.
- 在他们的评估中，B of A Securities的一位分析师给出了中立评级，目标价为18美元。
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Novavax options trades with real-time alerts from Benzinga Pro.
期权交易存在更高的风险和潜在回报。精明的交易者通过不断学习、调整策略、监测多个因子并密切关注市场走势来管理这些风险。通过Benzinga Pro即时警报，了解最新的诺瓦瓦克斯医药期权交易情况。